Shannon K. McWeeney focuses on Genetics, Cancer research, Leukemia, Molecular biology and Computational biology. His biological study spans a wide range of topics, including Reference population and Genetic diversity. His Cancer research research is multidisciplinary, incorporating elements of Androgen deprivation therapy, Prostate cancer, Androgen receptor and Endocrinology.
Many of his research projects under Leukemia are closely connected to Atypical chronic myeloid leukemia with Atypical chronic myeloid leukemia, tying the diverse disciplines of science together. His work carried out in the field of Chronic myelogenous leukemia brings together such families of science as Mutation, Imatinib, Imatinib mesylate and Proto-oncogene tyrosine-protein kinase Src. His Computational biology study combines topics from a wide range of disciplines, such as Single-nucleotide polymorphism, Gene regulatory network and Genome, Genomics.
His primary areas of study are Cancer research, Genetics, Myeloid leukemia, Gene and Leukemia. His Cancer research study integrates concerns from other disciplines, such as Mutation, Cancer and Drug resistance. His research on Mutation often connects related topics like Molecular biology.
Progenitor cell and CD34 is closely connected to Bone marrow in his research, which is encompassed under the umbrella topic of Myeloid leukemia. His work on Chronic myelogenous leukemia as part of his general Leukemia study is frequently connected to Acute lymphocytic leukemia, thereby bridging the divide between different branches of science. Shannon K. McWeeney studied Transcriptome and Computational biology that intersect with Bioinformatics.
The scientist’s investigation covers issues in Cancer research, Myeloid leukemia, Leukemia, Computational biology and Cancer. His studies in Cancer research integrate themes in fields like Crenolanib, Drug resistance and Chronic lymphocytic leukemia. The various areas that Shannon K. McWeeney examines in his Drug resistance study include Cell culture and Neuroblastoma RAS viral oncogene homolog.
Shannon K. McWeeney works mostly in the field of Leukemia, limiting it down to concerns involving T cell and, occasionally, Cytotoxic T cell, Asymptomatic and Immunophenotyping. Shannon K. McWeeney combines subjects such as Transcriptome, Gene and Genomics with his study of Computational biology. To a larger extent, he studies Genetics with the aim of understanding RNA-Seq.
His primary areas of investigation include Computational biology, Cancer research, Myeloid leukemia, Leukemia and Myeloid. Shannon K. McWeeney integrates many fields in his works, including Computational biology and Context. His Cancer research research incorporates elements of Gene expression, Prostate cancer, Androgen receptor, Chronic lymphocytic leukemia and Acute leukemia.
His Myeloid leukemia research integrates issues from Venetoclax, Germline mutation, Molecular pathology and Drug resistance. His studies deal with areas such as Cellular differentiation, Cytokine, Paracrine signalling, Tumor microenvironment and Hepatocyte growth factor as well as Leukemia. The Myeloid study combines topics in areas such as Lineage, Transcription factor, CEBPA, Genomics and Growth factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Defining the CREB Regulon: A Genome-Wide Analysis of Transcription Factor Regulatory Regions
Soren Impey;Sean R. McCorkle;Hyunjoo Cha-Molstad;Jami M. Dwyer.
The BioPAX community standard for pathway data sharing
Emek Demir;Emek Demir;Michael P. Cary;Suzanne Paley;Ken Fukuda.
Nature Biotechnology (2010)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr.
The Lancet (2020)
The genome architecture of the collaborative cross mouse genetic reference population
Fuad A. Iraqi;Mustafa Mahajne;Yasser Salaymah;Hani Sandovski.
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson;Jason Gotlib;Daniel A. Pollyea;Angela G. Fleischman.
The New England Journal of Medicine (2013)
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy.
Stephanie G. Willis;Thoralf Lange;Thoralf Lange;Thoralf Lange;Shadmehr Demehri;Shadmehr Demehri;Shadmehr Demehri;Sandra Otto;Sandra Otto;Sandra Otto.
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease
P. Hemachandra Reddy;Shannon McWeeney;Byung S. Park;Maria Manczak.
Human Molecular Genetics (2004)
MIFlowCyt: the minimum information about a Flow Cytometry Experiment.
Jamie A. Lee;Josef Spidlen;Keith Boyce;Jennifer Cai.
Cytometry Part A (2008)
Functional genomic landscape of acute myeloid leukaemia.
Jeffrey W. Tyner;Cristina E. Tognon;Cristina E. Tognon;Daniel Bottomly;Beth Wilmot.
Evaluating Gene Expression in C57BL/6J and DBA/2J Mouse Striatum Using RNA-Seq and Microarrays
Daniel Bottomly;Nicole A. R. Walter;Nicole A. R. Walter;Jessica Ezzell Hunter;Priscila Darakjian.
PLOS ONE (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: